View Past PerformanceThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsBiofactory バランスシートの健全性財務の健全性 基準チェック /36Biofactoryの総株主資本はPLN5.9M 、総負債はPLN4.6Mで、負債比率は76.7%となります。総資産と総負債はそれぞれPLN13.3MとPLN7.3Mです。 Biofactoryの EBIT はPLN99.6Kで、利息カバレッジ比率0.2です。現金および短期投資はPLN26.5Kです。主要情報76.66%負債資本比率zł4.56m負債インタレスト・カバレッジ・レシオ0.2x現金zł26.52kエクイティzł5.95m負債合計zł7.32m総資産zł13.26m財務の健全性に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Apr 19Biofactory S.A., Annual General Meeting, May 13, 2024Biofactory S.A., Annual General Meeting, May 13, 2024, at 09:00 Central European Standard Time.Reported Earnings • Feb 18Full year 2023 earnings released: zł0.10 loss per share (vs zł0.56 profit in FY 2022)Full year 2023 results: zł0.10 loss per share (down from zł0.56 profit in FY 2022). Revenue: zł14.6m (down 13% from FY 2022). Net loss: zł196.0k (down 119% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.Buy Or Sell Opportunity • Feb 08Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 16% to zł3.94. The fair value is estimated to be zł3.23, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 9.9% over the last 3 years. Meanwhile, the company became loss making.Buy Or Sell Opportunity • Jan 19Now 31% overvaluedOver the last 90 days, the stock has fallen 6.2% to zł3.94. The fair value is estimated to be zł3.01, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 9.9% over the last 3 years. Meanwhile, the company became loss making.お知らせ • Jan 07Biofactory S.A. to Report Q1, 2024 Results on May 14, 2024Biofactory S.A. announced that they will report Q1, 2024 results on May 14, 2024お知らせ • Jan 06+ 3 more updatesBiofactory S.A. to Report Q3, 2024 Results on Nov 14, 2024Biofactory S.A. announced that they will report Q3, 2024 results on Nov 14, 2024分析記事 • Nov 04A Look At The Intrinsic Value Of Biofactory S.A. (WSE:BFC)Key Insights The projected fair value for Biofactory is zł3.09 based on Dividend Discount Model Biofactory's zł3.50...Valuation Update With 7 Day Price Move • Oct 24Investor sentiment improves as stock rises 18%After last week's 18% share price gain to zł4.14, the stock trades at a trailing P/E ratio of 18.8x. Average trailing P/E is 15x in the Forestry industry in Poland. Total returns to shareholders of 71% over the past three years.Valuation Update With 7 Day Price Move • Oct 05Investor sentiment improves as stock rises 18%After last week's 18% share price gain to zł3.78, the stock trades at a trailing P/E ratio of 17.2x. Average trailing P/E is 13x in the Forestry industry in Poland. Total returns to shareholders of 56% over the past three years.Valuation Update With 7 Day Price Move • Sep 14Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to zł3.80, the stock trades at a trailing P/E ratio of 17.3x. Average trailing P/E is 15x in the Forestry industry in Poland. Total returns to shareholders of 17% over the past three years.Reported Earnings • Aug 02Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: zł3.63m (down 24% from 2Q 2022). Net loss: zł5.8k (down 102% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jun 20Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to zł4.00, the stock trades at a trailing P/E ratio of 10.7x. Average trailing P/E is 11x in the Forestry industry in Poland. Total returns to shareholders of 76% over the past three years.Upcoming Dividend • Jun 06Upcoming dividend of zł0.30 per share at 6.7% yieldEligible shareholders must have bought the stock before 13 June 2023. Payment date: 27 June 2023. Payout ratio is on the higher end at 80%, and the cash payout ratio is above 100%. Trailing yield: 6.7%. Lower than top quartile of Polish dividend payers (7.4%). Higher than average of industry peers (5.6%).お知らせ • May 09Biofactory S.A., Annual General Meeting, Jun 02, 2023Biofactory S.A., Annual General Meeting, Jun 02, 2023, at 10:00 Central European Standard Time.Reported Earnings • Feb 02Full year 2022 earnings released: EPS: zł0.56 (vs zł0.56 in FY 2021)Full year 2022 results: EPS: zł0.56 (down from zł0.56 in FY 2021). Revenue: zł16.7m (up 5.6% from FY 2021). Net income: zł1.06m (flat on FY 2021). Profit margin: 6.3% (down from 6.7% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jan 16Investor sentiment improved over the past weekAfter last week's 19% share price gain to zł4.52, the stock trades at a trailing P/E ratio of 9.4x. Average trailing P/E is 11x in the Forestry industry in Poland. Total returns to shareholders of 87% over the past three years.Valuation Update With 7 Day Price Move • Dec 16Investor sentiment improved over the past weekAfter last week's 20% share price gain to zł3.98, the stock trades at a trailing P/E ratio of 8.3x. Average trailing P/E is 9x in the Forestry industry in Poland. Total returns to shareholders of 65% over the past three years.Valuation Update With 7 Day Price Move • Nov 30Investor sentiment improved over the past weekAfter last week's 25% share price gain to zł3.64, the stock trades at a trailing P/E ratio of 7.6x. Average trailing P/E is 9x in the Forestry industry in Poland. Total returns to shareholders of 70% over the past three years.お知らせ • Nov 03+ 4 more updatesBiofactory S.A. to Report Q2, 2023 Results on Jul 31, 2023Biofactory S.A. announced that they will report Q2, 2023 results on Jul 31, 2023Reported Earnings • Aug 02Second quarter 2022 earnings released: EPS: zł0.15 (vs zł0.38 in 2Q 2021)Second quarter 2022 results: EPS: zł0.15 (down from zł0.38 in 2Q 2021). Revenue: zł4.79m (up 12% from 2Q 2021). Net income: zł288.2k (down 60% from 2Q 2021). Profit margin: 6.0% (down from 17% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jul 28Investor sentiment improved over the past weekAfter last week's 22% share price gain to zł4.36, the stock trades at a trailing P/E ratio of 6.2x. Average trailing P/E is 14x in the Forestry industry in Poland. Total returns to shareholders of 114% over the past three years.分析記事 • Jul 11Should You Be Adding Biofactory (WSE:BFC) To Your Watchlist Today?For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Valuation Update With 7 Day Price Move • Jun 20Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to zł3.60, the stock trades at a trailing P/E ratio of 5.1x. Average trailing P/E is 7x in the Forestry industry in Poland. Total returns to shareholders of 72% over the past three years.Upcoming Dividend • Jun 03Upcoming dividend of zł0.27 per shareEligible shareholders must have bought the stock before 10 June 2022. Payment date: 22 June 2022. Payout ratio is a comfortable 38% and this is well supported by cash flows. Trailing yield: 6.1%. Lower than top quartile of Polish dividend payers (7.9%). Higher than average of industry peers (3.2%).お知らせ • May 03Biofactory S.A., Annual General Meeting, Jun 02, 2022Biofactory S.A., Annual General Meeting, Jun 02, 2022, at 10:00 Central European Standard Time.Reported Earnings • Feb 02Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: zł0.55 (up from zł0.045 in FY 2020). Revenue: zł15.9m (up 38% from FY 2020). Net income: zł1.04m (up zł952.8k from FY 2020). Profit margin: 6.5% (up from 0.7% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Dec 22Investor sentiment deteriorated over the past weekAfter last week's 23% share price decline to zł3.60, the stock trades at a trailing P/E ratio of 4.9x. Average trailing P/E is 12x in the Forestry industry in Poland. Total returns to shareholders of 48% over the past three years.Valuation Update With 7 Day Price Move • Nov 04Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to zł4.36, the stock trades at a trailing P/E ratio of 5.9x. Average trailing P/E is 12x in the Forestry industry in Poland. Total returns to shareholders of 73% over the past three years.Valuation Update With 7 Day Price Move • Oct 21Investor sentiment improved over the past weekAfter last week's 18% share price gain to zł4.78, the stock trades at a trailing P/E ratio of 8.2x. Average trailing P/E is 12x in the Forestry industry in Poland. Total returns to shareholders of 89% over the past three years.Reported Earnings • Aug 04Second quarter 2021 earnings releasedThe company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: zł4.28m (up 57% from 2Q 2020). Net income: zł715.4k (up zł890.7k from 2Q 2020). Profit margin: 17% (up from net loss in 2Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 59% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Aug 03Investor sentiment improved over the past weekAfter last week's 37% share price gain to zł4.42, the stock trades at a trailing P/E ratio of 35.6x. Average trailing P/E is 20x in the Forestry industry in Poland. Total returns to shareholders of 44% over the past three years.Upcoming Dividend • Jun 25Upcoming dividend of zł0.15 per shareEligible shareholders must have bought the stock before 02 July 2021. Payment date: 26 August 2021. Trailing yield: 4.2%. Lower than top quartile of Polish dividend payers (5.8%). Higher than average of industry peers (2.8%).Valuation Update With 7 Day Price Move • Jun 01Investor sentiment improved over the past weekAfter last week's 15% share price gain to zł3.64, the stock trades at a trailing P/E ratio of 29.3x. Average trailing P/E is 20x in the Forestry industry in Poland. Total returns to shareholders of 40% over the past three years.Valuation Update With 7 Day Price Move • May 04Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to zł3.30, the stock trades at a trailing P/E ratio of 73.8x. Average trailing P/E is 22x in the Forestry industry in Poland. Total returns to shareholders of 27% over the past three years.Valuation Update With 7 Day Price Move • Feb 04Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to zł3.30, the stock is trading at a trailing P/E ratio of 73.8x, down from the previous P/E ratio of 89x. This compares to an average P/E of 25x in the Forestry industry in Poland. Total returns to shareholders over the past three years are 18%.分析記事 • Feb 03Calculating The Fair Value Of Biofactory S.A. (WSE:BFC)How far off is Biofactory S.A. ( WSE:BFC ) from its intrinsic value? Using the most recent financial data, we'll take a...Reported Earnings • Feb 03Full year 2020 earnings released: EPS zł0.045 (vs zł0.24 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: zł11.5m (down 11% from FY 2019). Net income: zł85.0k (down 82% from FY 2019). Profit margin: 0.7% (down from 3.6% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.お知らせ • Dec 12+ 4 more updatesBiofactory S.A. to Report Q3, 2021 Results on Oct 29, 2021Biofactory S.A. announced that they will report Q3, 2021 results on Oct 29, 2021財務状況分析短期負債: BFCの 短期資産 ( PLN4.8M ) が 短期負債 ( PLN2.7M ) を超えています。長期負債: BFCの短期資産 ( PLN4.8M ) が 長期負債 ( PLN4.6M ) を上回っています。デット・ツー・エクイティの歴史と分析負債レベル: BFCの 純負債対資本比率 ( 76.2% ) は 高い と見なされます。負債の削減: BFCの負債対資本比率は、過去 5 年間で124.2%から76.7%に減少しました。債務返済能力: BFCの負債は 営業キャッシュフロー によって 十分にカバーされていません ( 13.9% )。インタレストカバレッジ: BFCの負債に対する 利息支払い は EBIT ( 0.2 x coverage) によって 十分にカバーされていません。貸借対照表健全な企業の発掘7D1Y7D1Y7D1YMaterials 業界の健全な企業。View Dividend企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2024/07/14 07:19終値2024/04/17 00:00収益2024/03/31年間収益2023/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Biofactory S.A. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Apr 19Biofactory S.A., Annual General Meeting, May 13, 2024Biofactory S.A., Annual General Meeting, May 13, 2024, at 09:00 Central European Standard Time.
Reported Earnings • Feb 18Full year 2023 earnings released: zł0.10 loss per share (vs zł0.56 profit in FY 2022)Full year 2023 results: zł0.10 loss per share (down from zł0.56 profit in FY 2022). Revenue: zł14.6m (down 13% from FY 2022). Net loss: zł196.0k (down 119% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.
Buy Or Sell Opportunity • Feb 08Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 16% to zł3.94. The fair value is estimated to be zł3.23, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 9.9% over the last 3 years. Meanwhile, the company became loss making.
Buy Or Sell Opportunity • Jan 19Now 31% overvaluedOver the last 90 days, the stock has fallen 6.2% to zł3.94. The fair value is estimated to be zł3.01, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 9.9% over the last 3 years. Meanwhile, the company became loss making.
お知らせ • Jan 07Biofactory S.A. to Report Q1, 2024 Results on May 14, 2024Biofactory S.A. announced that they will report Q1, 2024 results on May 14, 2024
お知らせ • Jan 06+ 3 more updatesBiofactory S.A. to Report Q3, 2024 Results on Nov 14, 2024Biofactory S.A. announced that they will report Q3, 2024 results on Nov 14, 2024
分析記事 • Nov 04A Look At The Intrinsic Value Of Biofactory S.A. (WSE:BFC)Key Insights The projected fair value for Biofactory is zł3.09 based on Dividend Discount Model Biofactory's zł3.50...
Valuation Update With 7 Day Price Move • Oct 24Investor sentiment improves as stock rises 18%After last week's 18% share price gain to zł4.14, the stock trades at a trailing P/E ratio of 18.8x. Average trailing P/E is 15x in the Forestry industry in Poland. Total returns to shareholders of 71% over the past three years.
Valuation Update With 7 Day Price Move • Oct 05Investor sentiment improves as stock rises 18%After last week's 18% share price gain to zł3.78, the stock trades at a trailing P/E ratio of 17.2x. Average trailing P/E is 13x in the Forestry industry in Poland. Total returns to shareholders of 56% over the past three years.
Valuation Update With 7 Day Price Move • Sep 14Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to zł3.80, the stock trades at a trailing P/E ratio of 17.3x. Average trailing P/E is 15x in the Forestry industry in Poland. Total returns to shareholders of 17% over the past three years.
Reported Earnings • Aug 02Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: zł3.63m (down 24% from 2Q 2022). Net loss: zł5.8k (down 102% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jun 20Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to zł4.00, the stock trades at a trailing P/E ratio of 10.7x. Average trailing P/E is 11x in the Forestry industry in Poland. Total returns to shareholders of 76% over the past three years.
Upcoming Dividend • Jun 06Upcoming dividend of zł0.30 per share at 6.7% yieldEligible shareholders must have bought the stock before 13 June 2023. Payment date: 27 June 2023. Payout ratio is on the higher end at 80%, and the cash payout ratio is above 100%. Trailing yield: 6.7%. Lower than top quartile of Polish dividend payers (7.4%). Higher than average of industry peers (5.6%).
お知らせ • May 09Biofactory S.A., Annual General Meeting, Jun 02, 2023Biofactory S.A., Annual General Meeting, Jun 02, 2023, at 10:00 Central European Standard Time.
Reported Earnings • Feb 02Full year 2022 earnings released: EPS: zł0.56 (vs zł0.56 in FY 2021)Full year 2022 results: EPS: zł0.56 (down from zł0.56 in FY 2021). Revenue: zł16.7m (up 5.6% from FY 2021). Net income: zł1.06m (flat on FY 2021). Profit margin: 6.3% (down from 6.7% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jan 16Investor sentiment improved over the past weekAfter last week's 19% share price gain to zł4.52, the stock trades at a trailing P/E ratio of 9.4x. Average trailing P/E is 11x in the Forestry industry in Poland. Total returns to shareholders of 87% over the past three years.
Valuation Update With 7 Day Price Move • Dec 16Investor sentiment improved over the past weekAfter last week's 20% share price gain to zł3.98, the stock trades at a trailing P/E ratio of 8.3x. Average trailing P/E is 9x in the Forestry industry in Poland. Total returns to shareholders of 65% over the past three years.
Valuation Update With 7 Day Price Move • Nov 30Investor sentiment improved over the past weekAfter last week's 25% share price gain to zł3.64, the stock trades at a trailing P/E ratio of 7.6x. Average trailing P/E is 9x in the Forestry industry in Poland. Total returns to shareholders of 70% over the past three years.
お知らせ • Nov 03+ 4 more updatesBiofactory S.A. to Report Q2, 2023 Results on Jul 31, 2023Biofactory S.A. announced that they will report Q2, 2023 results on Jul 31, 2023
Reported Earnings • Aug 02Second quarter 2022 earnings released: EPS: zł0.15 (vs zł0.38 in 2Q 2021)Second quarter 2022 results: EPS: zł0.15 (down from zł0.38 in 2Q 2021). Revenue: zł4.79m (up 12% from 2Q 2021). Net income: zł288.2k (down 60% from 2Q 2021). Profit margin: 6.0% (down from 17% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jul 28Investor sentiment improved over the past weekAfter last week's 22% share price gain to zł4.36, the stock trades at a trailing P/E ratio of 6.2x. Average trailing P/E is 14x in the Forestry industry in Poland. Total returns to shareholders of 114% over the past three years.
分析記事 • Jul 11Should You Be Adding Biofactory (WSE:BFC) To Your Watchlist Today?For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Valuation Update With 7 Day Price Move • Jun 20Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to zł3.60, the stock trades at a trailing P/E ratio of 5.1x. Average trailing P/E is 7x in the Forestry industry in Poland. Total returns to shareholders of 72% over the past three years.
Upcoming Dividend • Jun 03Upcoming dividend of zł0.27 per shareEligible shareholders must have bought the stock before 10 June 2022. Payment date: 22 June 2022. Payout ratio is a comfortable 38% and this is well supported by cash flows. Trailing yield: 6.1%. Lower than top quartile of Polish dividend payers (7.9%). Higher than average of industry peers (3.2%).
お知らせ • May 03Biofactory S.A., Annual General Meeting, Jun 02, 2022Biofactory S.A., Annual General Meeting, Jun 02, 2022, at 10:00 Central European Standard Time.
Reported Earnings • Feb 02Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: zł0.55 (up from zł0.045 in FY 2020). Revenue: zł15.9m (up 38% from FY 2020). Net income: zł1.04m (up zł952.8k from FY 2020). Profit margin: 6.5% (up from 0.7% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Dec 22Investor sentiment deteriorated over the past weekAfter last week's 23% share price decline to zł3.60, the stock trades at a trailing P/E ratio of 4.9x. Average trailing P/E is 12x in the Forestry industry in Poland. Total returns to shareholders of 48% over the past three years.
Valuation Update With 7 Day Price Move • Nov 04Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to zł4.36, the stock trades at a trailing P/E ratio of 5.9x. Average trailing P/E is 12x in the Forestry industry in Poland. Total returns to shareholders of 73% over the past three years.
Valuation Update With 7 Day Price Move • Oct 21Investor sentiment improved over the past weekAfter last week's 18% share price gain to zł4.78, the stock trades at a trailing P/E ratio of 8.2x. Average trailing P/E is 12x in the Forestry industry in Poland. Total returns to shareholders of 89% over the past three years.
Reported Earnings • Aug 04Second quarter 2021 earnings releasedThe company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: zł4.28m (up 57% from 2Q 2020). Net income: zł715.4k (up zł890.7k from 2Q 2020). Profit margin: 17% (up from net loss in 2Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 59% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Aug 03Investor sentiment improved over the past weekAfter last week's 37% share price gain to zł4.42, the stock trades at a trailing P/E ratio of 35.6x. Average trailing P/E is 20x in the Forestry industry in Poland. Total returns to shareholders of 44% over the past three years.
Upcoming Dividend • Jun 25Upcoming dividend of zł0.15 per shareEligible shareholders must have bought the stock before 02 July 2021. Payment date: 26 August 2021. Trailing yield: 4.2%. Lower than top quartile of Polish dividend payers (5.8%). Higher than average of industry peers (2.8%).
Valuation Update With 7 Day Price Move • Jun 01Investor sentiment improved over the past weekAfter last week's 15% share price gain to zł3.64, the stock trades at a trailing P/E ratio of 29.3x. Average trailing P/E is 20x in the Forestry industry in Poland. Total returns to shareholders of 40% over the past three years.
Valuation Update With 7 Day Price Move • May 04Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to zł3.30, the stock trades at a trailing P/E ratio of 73.8x. Average trailing P/E is 22x in the Forestry industry in Poland. Total returns to shareholders of 27% over the past three years.
Valuation Update With 7 Day Price Move • Feb 04Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to zł3.30, the stock is trading at a trailing P/E ratio of 73.8x, down from the previous P/E ratio of 89x. This compares to an average P/E of 25x in the Forestry industry in Poland. Total returns to shareholders over the past three years are 18%.
分析記事 • Feb 03Calculating The Fair Value Of Biofactory S.A. (WSE:BFC)How far off is Biofactory S.A. ( WSE:BFC ) from its intrinsic value? Using the most recent financial data, we'll take a...
Reported Earnings • Feb 03Full year 2020 earnings released: EPS zł0.045 (vs zł0.24 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: zł11.5m (down 11% from FY 2019). Net income: zł85.0k (down 82% from FY 2019). Profit margin: 0.7% (down from 3.6% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.
お知らせ • Dec 12+ 4 more updatesBiofactory S.A. to Report Q3, 2021 Results on Oct 29, 2021Biofactory S.A. announced that they will report Q3, 2021 results on Oct 29, 2021